NeuBase Therapeutics Inc - ESG Rating & Company Profile powered by AI
This webpage is a free Environmental, Social and Governance assessment covering NeuBase Therapeutics Inc. The page includes a Q&A section on NeuBase Therapeutics Inc. If you are employed by NeuBase Therapeutics Inc and you would like to licence your ESG rating, please get in touch.
NeuBase Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 2.7, social score of 4.8 and governance score of 8.0.
5.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 658 | Transchem Ltd | 5.3 | High |
| 658 | Zenith Healthcare Ltd | 5.3 | High |
| 687 | NeuBase Therapeutics Inc | 5.2 | High |
| 687 | Cardiol Therapeutics Inc | 5.2 | High |
| 687 | Cell Source Inc | 5.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does NeuBase Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes NeuBase Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes NeuBase Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes NeuBase Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes NeuBase Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes NeuBase Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes NeuBase Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes NeuBase Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid NeuBase Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes NeuBase Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas NeuBase Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes NeuBase Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes NeuBase Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs NeuBase Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes NeuBase Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes NeuBase Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes NeuBase Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for NeuBase Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.